Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

Показать другие версии (1)

BACKGROUND: Maternal antibodies give neonates some protection against bacterial infection. We measured antibodies against Neisseria meningitidis serogroups A, C, Y and W135 in mothers and their 2-month-old infants at study enrollment. We also assessed the impact of maternal antibody present at 2 mo...

Полное описание

Библиографические подробности
Главные авторы:	Blanchard-Rohner, G, Snape, MD, Kelly, D, O'Connor, D, John, T, Kibwana, E, Parks, H, Ford, K, Dull, P, Pollard, A
Формат:	Journal article
Язык:	English
Опубликовано:	2013

Схожие документы

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis serogroups A, C, y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom
по: Blanchard-Rohner, G, и др.
Опубликовано: (2013)

Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children
по: Marzia Monica Giuliani, и др.
Опубликовано: (2021-05-01)

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.
по: Blanchard-Rohner, G, и др.
Опубликовано: (2013)

Neisseria meningitidis Serogroup W135, China
по: Zhujun Shao, и др.
Опубликовано: (2010-02-01)

The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age
по: Blanchard-Rohner, G, и др.
Опубликовано: (2013)

Carriage of Neisseria meningitidis Serogroup W135 ST-2881
по: Pascal Boisier, и др.
Опубликовано: (2006-09-01)

Hajj-Related Neisseria Meningitidis Serogroup W135 in Mauritius
по: Mohammad Iqbal Issack, и др.
Опубликовано: (2002-03-01)

Travel-related Neisseria meningitidis Serogroup W135 Infection, France
по: Muhamed-Kheir Taha, и др.
Опубликовано: (2013-06-01)

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
по: Hoan Jong Lee, и др.
Опубликовано: (2014-11-01)

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?
по: Katharina Schley, и др.
Опубликовано: (2023-05-01)

Neisseria meningitidis Serogroup W135 Isolates Associated with the ET-37 Complex
по: Tanja Popovic, и др.
Опубликовано: (2000-08-01)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
по: Lidia Serra, и др.
Опубликовано: (2021-07-01)

Towards an improved serogroup B Neisseria meningitidis vaccine.
по: Perrett, K, и др.
Опубликовано: (2005)

Real-world impact and effectiveness of MenACWY-TT
по: Rodolfo Villena, и др.
Опубликовано: (2023-08-01)

New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.
по: Suzanne Chanteau, и др.
Опубликовано: (2006-09-01)

Recent Increase in Meningitis Caused by Neisseria meningitidis Serogroups A and W135, Yaoundé, Cameroon
по: Marie-Christine Fonkoua, и др.
Опубликовано: (2002-03-01)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
по: Khatami, A, и др.
Опубликовано: (2012)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
по: Khatami, A, и др.
Опубликовано: (2012)

A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty
по: Andrews, S, и др.
Опубликовано: (2014)

A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty.
по: Andrews, S, и др.
Опубликовано: (2014)

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
по: Carr, JP, и др.
Опубликовано: (2022)

Neisseria meningitidis W135, Turkey
по: Levent Doganci, и др.
Опубликовано: (2004-05-01)

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.
по: Xie, O, и др.
Опубликовано: (2012)

Neisseria meningitidis Strain of Unknown Serogroup, China
по: Haijian Zhou, и др.
Опубликовано: (2011-03-01)

Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile
по: María Gabriela Graña, и др.
Опубликовано: (2021-12-01)

Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination
по: Cynthia Burman, и др.
Опубликовано: (2024-12-01)

Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil
по: David E Barroso, и др.
Опубликовано: (2007-09-01)

Characterization of Unusual Serogroups of <i>Neisseria meningitidis</i>
по: Samy Taha, и др.
Опубликовано: (2024-12-01)

Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin
по: Jacob Strahilevitz, и др.
Опубликовано: (2008-10-01)

The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.
по: Valerian B Pinto, и др.
Опубликовано: (2013-01-01)

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
по: Timo Vesikari, и др.
Опубликовано: (2020-06-01)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
по: Blanchard-Rohner, G, и др.
Опубликовано: (2012)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine.
по: Blanchard-Rohner, G, и др.
Опубликовано: (2012)

Distribution of Serogroups and Genotypes among Neisseria Meningitidis Strains in Malaysia
по: Kuppusamy, Puvanesvari
Опубликовано: (2009)

Neisseria meningitidis serogroup X sequence type 767 in Turkey.
по: Kiliç, A, и др.
Опубликовано: (2010)

Correction: Molecular Epidemiology of Neisseria meningitidis Serogroup B in Brazil
Опубликовано: (2012-01-01)

Neisseria meningitidis Serogroup X Sequence Type 2888, Italy
по: Cecilia Fazio, и др.
Опубликовано: (2010-02-01)

Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness
по: Ray Borrow, и др.
Опубликовано: (2023-12-01)

Evaluation of monoclonal antibodies to the capsular polysaccharide of Neisseria meningitidis serogroups A, C, Y, W and X to be used in the identity assays
по: Osmir Cabrera-Blanco, и др.
Опубликовано: (2015-11-01)

Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections
по: Sebastiaan J. van Hal, и др.
Опубликовано: (2025-01-01)